Lyndsay Fisher
Physician
Also affiliated: Arkansas Children's Hospital (2023); University of Mobile (2023); University of South Alabama (2023)
Graduate Student Researcher
College of Medicine Administration
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Lyndsay Fisher's research focuses on the identification and treatment of infections in pediatric oncology patients. Her work includes prospective studies to validate models predicting bloodstream infection risk in febrile, non-neutropenic children with cancer. She has also investigated methods to reduce the time to antibiotic administration for febrile neutropenic patients in emergency settings. Fisher's scholarship also extends to unusual cases, such as a fatal tick-borne disease presenting as an HLH-like syndrome in an infant. Her collaborators at the University of Arkansas for Medical Sciences include Kevin Bielamowicz, Salim Aljabari, Steven Dahl, and Hannah Wilkins, with whom she has co-authored publications.
Metrics
- h-index: 1
- Publications: 3
- Citations: 14
Selected Publications
-
828: FATAL TICK-BORNE DISEASE IN A VERY YOUNG INFANT: AN UNUSUAL DRIVER OF HLH-LIKE SYNDROME (2023)
-
Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer (2023)
-
Reducing the time of antibiotic administration to febrile neutropenic patients in the emergency room (2023)
Collaboration Network
Top Collaborators
- Reducing the time of antibiotic administration to febrile neutropenic patients in the emergency room
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Similar Researchers
Based on overlapping research topics